Description
A review of Moderna’s Infectious Disease Core mRNA Science and Technology that enables a platform for Precision Medicine. This symposium will provide an overview of the research process including a description of how we approach antigen selection and design to drive protective immunity against a given pathogen, a review of Immunological assessments that we employ to assess vaccine approaches and selection of the best strategy, and how we assess the responses that we elicit. Finally, we will discuss the CMV vaccine program, including a review of the vaccine construct, Phase 1 and Phase 2 data, and the Phase 3 study design.